Scancell Holdings plc (AIM:SCLP)
London · Delayed Price · Currency is GBP · Price in GBX 15.62
-0.63 (-3.88%)
May 6, 2026, 4:11 PM GMT
Scancell Holdings Market Cap
Scancell Holdings has a market cap or net worth of 168.64 million as of May 6, 2026. Its market cap has increased by 40.91% in one year.
Market Cap
168.64M
Enterprise Value
176.25M
Revenue
4.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.62
Market Cap Chart
Since June 29, 2009, Scancell Holdings's market cap has increased from 3.13M to 168.64M, an increase of 5,280.89%. That is a compound annual growth rate of 26.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 168.64M | 64.14% |
| Dec 31, 2025 | 102.74M | -6.96% |
| Dec 31, 2024 | 110.43M | 28.31% |
| Dec 29, 2023 | 86.06M | -57.34% |
| Dec 30, 2022 | 201.77M | 23.75% |
| Dec 31, 2021 | 163.04M | 42.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oxford Biomedica | 735.08M |
| Avacta Group | 349.02M |
| PureTech Health | 306.71M |
| Bioventix | 88.82M |
| Faron Pharmaceuticals Oy | 82.80M |
| 4basebio | 78.16M |
| Ondine Biomedical | 62.35M |
| hVIVO | 50.15M |